Gyre Therapeutics, Inc. Common Stock
$5.960
USD
Last updated on --.
24h volume81.59K
24h highest6.0600 USD
24h lowest5.9000 USD
24h Price movement-1.65%
GYRE recent prices
24 Hours
-1.65%-$0.1
30 days
-16.83%-$1.225
60 days
-21.26%-$1.635
90 days
-21.11%-$1.595
Key data
Previous close6.0600 USD
Market cap610.31M USD
Volume81.59K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount0.24000 USD
Next ex-dividend dateJan 13, 2023
Next payment dateJan 12, 2023
EPS diluted (TTM)-0.07000 USD
Net income (FY)-3.71M USD
Revenue (FY)117.05M USD
Last report dateMay 8, 2026
About Gyre Therapeutics, Inc. Common Stock
HeadquartersSAN DIEGO
Employees (FY)618.00
Revenue per employee (FY)189.40K USD
Net income per employee (FY)-6.01K USD
Listed onNasdaq
GYRE conversion tables
 |  |
|---|---|
| 0.5 GYRE | 2.980 USD |
| 1 GYRE | 5.960 USD |
| 5 GYRE | 29.8 USD |
| 10 GYRE | 59.6 USD |
| |
|---|---|
| 0.5 USD | 0.083893 GYRE |
| 1 USD | 0.16779 GYRE |
| 5 USD | 0.83893 GYRE |
| 10 USD | 1.677 GYRE |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
GYRE is trading at $5.960, -1.65% over the last 24 hours. Track live moves on the price chart at the top of this page.
The GYRE stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. GYRE is currently trading at $5.960, -1.65% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on GYRE price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. GYRE's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from GYRE; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against GYRE's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Gyre Therapeutics, Inc. Common Stock's market cap is currently 610.31M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume81.59K
24h highest6.0600 USD
24h lowest5.9000 USD
24h Price movement-1.65%
Start trade with GYRE Perpetual
Sign up to trade